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Executive Summary:

The blood brain barrier is the protector of the central nervous system and a physical barrier that
functions to regulate the substances that can pass in and out of the brain; it is the function and integrity of
this system that keeps the homeostasis of the central nervous system. Yet this shield against foreign
invaders in the blood also prevents drugs designed for treatment of various ailments of the central nervous
system from reaching their target in the brain. Developing drugs that can pass through this barrier, and
understanding it’s function has become an area of increasing interest. Many researchers and companies
are turning to in vitro models of the blood brain barrier to test a drugs ability to pass through this shield
and target areas in the central nervous system. Our lab at Cal Poly focuses on developing blood vessel
mimics, and tissue engineered constructs that would allow for in vitro modeling and testing of blood
vessel physiology. Currently the main focus is on coronary blood vessels for stent testing, but expanding
this to other areas of blood vessel research is of interest to our lab, and we believe that we can contribute
to the blood brain barrier field by using our labs experience with other tissue engineering constructs. The
focus of this project is to design and create aspects of a novel bioreactor that is reusable, can be built inhouse, and facilitates better access to the scaffolding. The primary areas of focus in this project were to
1) design and manufacture a reusable novel bioreactor in-house, 2) create a mandrel to collect
electrospun fibers to be used as scaffolding, and 3) to evaluate these scaffolds and compare to the
literatures characteristics of proper scaffolds for blood brain barrier models. All of these goals were met;
we now have a bioreactor prototype that has been manufactured and is currently going through further
refinement, modification and testing to optimize the design, there is now series of new mandrels that are
ready to be used to electrospin scaffolds to be used in the new bioreactor, and the scaffolds have been
shown to possess some of the characteristics that were outlined in the literature for blood brain barrier
models. The completion of all of these aims has allowed for the advancement and progress towards the
ultimate goal of creating an in vitro model of the blood brain barrier to study it’s physiologic mechanisms
and study drug diffusion. The project will allow for research and advancement in the area of developing
pharmacological therapies and strategies for treating disorders and ailments of the central nervous system.
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Introduction:
The blood brain barrier plays a crucial role in protecting the brain and regulating its homeostatic
environment. This is very important to maintaining the functional performance of the brain. The
structure and nature of the blood brain barrier make it difficult for pharmacologic treatments to enter the
central nervous system from the blood in order to treat various diseases [1]. This highlights the
importance of creating a model of the blood brain barrier that would allow further study of the
characteristics of the system, and gain increased knowledge into creating products that can cross this
barrier and treat brain related conditions and diseases [2].

Anatomy of the Blood Brain Barrier
The blood brain barrier refers to the capillaries that supply the brain with nutrients and remove
waste. It also functions to control the passage of various solutes into the region of the brain, making it a
means of defense for the brain against foreign invaders such as bacteria. These capillaries are comprised
of endothelial cells which make up the inner layer of all blood circulating vessels. What differentiates
this capillary system from others is the selective nature of the endothelial cells, which is characterized by
the tight-junctions that exist between the cells; however, these cells also show less of an ability to allow
things to pass pinocytotically. The tight junctions prevent solutes from passing in between cells that
comprise the vessel wall, and allow for the control of the homeostasis of the brain, and its functionality
[3,4].
The vessel lumen is circumnavigated by a single endothelial cell, rather than numerous cells lined
end to end as would characterize larger vessels. Attached to the outer wall of the endothelial cells are
pericytes, and beyond this are astrocytes [3]. There is not much information in literature on the exact
function of pericytes and more of the research has been on astrocytes. Astrocytes are glial cells which
have various functions inside the central nervous system. They have out stretched ‘feet’ which extend out
from their main body, and attach to the endothelial cells of the blood brain barrier [1]. They also provide
structural support to the nervous system, control the flow of neurotransmitters and ions in order to
maintain function of the nervous system. It has also been recently shown that astrocytes help to improve
the functional characteristics of the blood brain barrier in vitro [5,6]. For the purposes of this project, we
have been using bovine aortic endothelial cells (BAEC’s), and for C6 glial (astrocyte) cells. These cell
types have been shown to be used in previous research on the blood brain barrier and will suit the
purposes of this project [1].
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Current Blood Brain Barrier Models:
Current testing of pharmacological products ability to cross the blood brain barrier is primarily
done in in vitro bioreactor systems. The use of in vivo systems has occurred; however, most systems used
are in vitro systems. The use of in vitro bioreactors allows for critical testing of drugs and the exclusion
of drugs that would be selected against by the blood brain barrier in in vivo systems [2,7]. It is believed
that the main conditions that must be met in order to recapitulate the phenotype of the blood brain barrier
is to 1) have endothelial cells exposed to shear stress within the lumen, and 2) be exposed to
differentiation factors that are believed to come from astrocytes [2]. Today, there are a few different in
vitro systems for modeling the blood brain barrier, and many of these systems are early in their design
and leave much to be desired.
Some groups have tried to create in vitro models in flat well plates by growing endothelial cells
on one side of a porous membrane, with astrocytes grown on the other side [8,9]. Other groups have tried
growing endothelial cells with differentiation factor media to induce the endothelial cells to express tight
junctions. The media that has been treated with differentiation factor media helps to resolve the issue of
using cell types from different species, which can cause complications [10].
The typical bioreactor for the purpose of modeling the blood brain barrier is composed of many
hollow fibers onto which the endothelial cells are grown. The CellMax© system which we had
previously been using was this type of bioreactor. Media flow is run through these hollow fibers to
simulate blood through a capillary tube, and more naturally recreate the in vivo environment by creating
luminal shear stress. They also include the use of co-cultured astrocytes in order to provide the
differentiation factors, or media treated with the differentiation factors. Pharmocologic agents can then
be placed into the intra-luminary media, and measurements can be made to determine the amount that
passes through the blood brain barrier constructs and into the extra-capillary space. This type of a
bioreactor system has been shown to more accurately mimic the blood brain barrier phenotype [11].

Bryan Brandon’s Project:
This project was initially started by a fellow student Bryan Brandon. Bryan’s focus in this project
was in three areas, 1) characterizing the CellMax© system, 2) working to develop protocols for handling
the cell types and 3)selecting the media to culture the cells in [12]. The hope was that laying out the
protocols for using this system overall would lay the groundwork for future work to be done by
improving various parts of the experiment. He later involved Ryan Woodhouse and me to work on
various aspects of the project. Bryan focused on using a commercial system from the company
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CellMax© and developing a protocol for it while Ryan focused on creating protocols using cell tracker
stains and tracking cell types in co cultures [12]. The commercial system can be seen in Figure 1. My
own area of focus was on creating a bioreactor so that we did not have to rely on the commercial products
which had various faults that we believed could be overcome to allow easier completion of experiments.
After Bryan and Ryan both graduated, new students were added to the team. TJ Eames was brought on to
assist with culturing the cells and Amin Mirzaaghaeian worked with me on the bioreactor design.

Figure 1: The above image shows the commercial CellMax© DUO system with the CellMax© hollow fiber bioreactor
cartridge. The bioreactor can be seen sitting on the bioreactor stage.

The blood brain barrier model protocol that Bryan developed used a co-culture of bovine aortic
endothelial cells and C6 glioma cells. Previous work [1, 15,11,16,17 for C6’s and 2,18, 15 for BAEC’s]
provided by other papers has shown that these cell types can be used to properly replicate the blood brain
barrier. In Bryan’s project he was able to develop a protocol for passing and culturing the cells [12].
The commercial system that Bryan worked with was the CellMax© DUO system with the
CellMax© hollow fiber bioreactor cartridge. In his protocol he worked to evaluate and characterize the
pump system in order to determine the correct flow rates that should be used with the CellMax© hollow
fiber bioreactor cartridge in order to create the proper shear stress forces on the cells within the lumens.
In the course of his work he was able to determine the pump setting that should be used, as well as the
correct pin size to use in order to create the proper shear stresses on the inside of the lumen’s [12].
The final test that Bryan investigated was the use of media during co-culture of the cell types.
The multitude of tests that he performed concluded that a 50:50 mixture of the C6 and BAEC’s media
resulted in the best cell growth for both cell types. These media combinations were shown to give the
cells the best proliferative rate and signs of normal cell vitality. The C6’s grew well in the BAEC’s media
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alone, however it was unknown if culturing the C6’s in the BAEC’s media could affect the gene
expression of the C6’s in the long run. Also the C6 media is less expensive than the BAEC’s media, and
in order to reduce our costs for this experiment, a solution of half C6 media and half BAEC’s media was
chosen to be the best choice [12].

Bioreactor Design
The Commercial Bioreactor System
The commercial bioreactor that Bryan used, shown previously in Figure 1, is characterized by a
plastic tubular housing that encapsulates the hollow fiber scaffolding that the cells are cultured on. There
are 60 polypropylene scaffolds that have been precoated with ProNectin™ F. The fibers had an inner
diameter of 480μm, a wall thickness of 150μm, and an average pore size of .2μm. The idea of this type of
bioreactor is to grow the cells in a 3-D dynamic environment to more accurately recapitulate the in vivo
system. The cells can be grown within the scaffolds or between the exteriors of the scaffolds, and the
scaffolds support gas exchange between the extra-tubular space and luminal space as seen in Figure 2.

Figure 2: A cross sectional view of the hollow fibers. The BAEC's cells will be grown on the inner surface of the
scaffolds, while the C6 glioma cells will be grown on the exterior of the scaffolds. The scaffold tubing allows for gas and
nutrient exchange between the inner and outer spaces of the tubing.

Limitations of the Commercial System
After the work that Bryan did with the CellMax© systems, we realized that the CellMax© DUO
bioreactor design left much to be desired. The first problem that we came across with the commercial
bioreactor was that some of the scaffolds within the bioreactor system were broken before our initial set
up of the system. This meant that when we would try to sod our cells on the interior of the scaffold
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tubing that the BAEC’s would be released into the extra-tubular space, and either die or grow on the
outside of the scaffolding. In a system where we are trying to recreate the cell layering that is normal in
native tissue, the loss or misplacement of cells is detrimental to the model.
The next thing that we noticed with the commercial CellMax© bioreactors, that actually was a
large flaw in our eyes, was the inability to reuse the system. The housing of the bioreactor had no way of
accessing the scaffolding within, removing these or replacing these. The only ports into the bioreactor
system were the inlet and outlet tubing ports meant to facilitate fluid flow, or media sampling. This
meant that once we had completed an experiment and wanted to analyze the scaffolding system to
determine the morphology of the cells and their characteristics, we had no way of getting to the cells.
Ideally we would be able to take the scaffolds out of the system, embed them in paraffin or some type of
holding medium and stain them for cell markers. Another technique to analyze them would be to fix the
cells onto the scaffolding and stain the cells to look for cell attachment on the luminal wall of the scaffold.
However, since the bioreactor doesn’t allow us to easily remove the scaffolding from the bioreactor,
performing these analyses becomes more difficult. In order to get to the scaffolding and perform analysis,
we had to cut the outer housing of the bioreactor. To do this we used a band saw with the help of Mr.
Martin Koch and Mr. Dave Laiho. Using the band saw we cut through the housing and the scaffolding at
each end of the bioreactor housing, an image of the bioreactor after being cut can be seen in Figure 3.
Cutting through the housing compromises the bioreactor housing, and to perform more experiments, more
bioreactors need to be purchased. Yet at $469 per bioreactor, our funding for this project would quickly
be depleted.
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Figure 3: The above image shows the hollow fiber bioreactor after being cut with a band saw. The inlet and outlet ports
to the luminal space were cut to allow removal of the scaffolding.

Another issue that arises with the lack of access to the scaffolds is the inability to perform time
trial experiments. We would like to be able to check our system by removing singular scaffolds as
experiments progress to check on the development of our blood brain barrier model. It would be
impossible to do this with the current bioreactor systems since removing a scaffold would require cutting
the bioreactor, thus compromising the system.
While the CellMax© bioreactor system allowed us to set the foundation for this project and gain
basic understandings of the components and requirements for creating a blood brain barrier model, there
were various shortcomings with the design. The flaws that we saw in the system were that they would
sometimes have scaffolds broken before the inoculation of cells into the system, they were not reusable
and were difficult to deconstruct for analysis, and would not allow for time-trial analysis. To remedy this,
we decided to undertake the goal of creating our own bioreactor that we could build in-house, was
reusable, and allowed access to the scaffolds without destroying the bioreactor.

Design Criteria for New Bioreactor
Our plan for a new bioreactor was to identify and resolve some of the issues with the commercial
bioreactor system. Our main concern with the commercial bioreactor was that it was not reusable. To
resolve this issue, we hoped to create a bioreactor that allowed for easy access to the scaffolds within the
housing, while still maintaining its integrity and not compromising sterility. This would also mean that
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the components that the bioreactor was made of needed to be able to be sterilized. By allowing access to
the scaffolding we addressed not only the issue of reusability, but it would allow us to perform time trial
studies as well, as we could now select scaffolds from the bioreactor, remove them, then close the system
and continue running the experiment. The issue with scaffolds being broken before the experiments
began was partly an issue of there being so many scaffolds within the bioreactor, so our design looks to
reduce the number of scaffolds so we can be sure of their integrity before performing an experiment.
Taking these factors into account, we can list our design criteria for the bioreactor as: 1)to be able to reuse
the bioreactor, 2) have easy access to the scaffolding, and 3) to be able to create the bioreactor in house.

Bioreactor Designs
In order to manufacture our own bioreactor and address the flaws of the commercial system, we
came up with various potential designs to choose from. These ranged from making slight modifications
to current in-house bioreactor systems we use, to completely manufacturing a new bioreactor. Among the
various designs, there were 3 main designs that we considered for creating our own bioreactor, all that we
envisioned would allow for better access to the scaffolding while still being reusable.
The first design that I had considered involved modifying the in-house bioreactors that we
currently use for the blood vessel mimics (BVM) experiments. The current bioreactor used for the blood
vessel mimics uses a Lock & Lock© Tupperware container as the bioreactor housing. These containers
are able to be autoclaved, and the Lock & Lock© system of securing the lid seals the container to prevent
any contamination from occurring during experiments. With the addition of various barbed and luer lock
fittings, inlet and outlet ports have been created in the container wall to allow for the placement of a
polymer construct onto which endothelial cells can be cultured for blood vessel mimic experiments. My
design would keep the housing system the same, but use a different interface within the bioreactor to hold
the scaffolds. The current system uses barbed fittings that ePTFE (expanded polytetrafluoroethylene)
scaffolds are slid over and then secured using suture to tighten the scaffold onto the barb. The new design
that I had created used a type of diffuser cap that fit onto luer lock fittings extending from the wall. The
larger end of the diffuser caps would have been open and allowed for polymer scaffolds to be glued into
place using medical adhesive. Similar designs had been used to secure the housing in other bioreactor
designs for this type of model [14]. This design would readily allow access to the scaffolds through
removing the lid of the container. Also the materials used in the container are able to repeatedly be
sterilized, so that the same bioreactor could be used over and over. A problem with this system is that
with the scaffoldings simply placed in the hollow ends of the diffuser caps and glued in, it would be hard
to remove the scaffolding for time trial experiments. It would also be hard to repeatedly get the same
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orientation of scaffolds. Also the diffuser caps would most likely need to be manufactured in-house as
there was limited availability of commercially available diffuser caps that would fit our needs for this
design. An initial sketch of this design can be seen in Figure 4.

Figure 4: Bioreactor design that incorporates use of Lock & Lock© housing, with cartridge of scaffolds that integrates into
the system.

The second design that we considered was more of a traditional bioreactor design. This design
would have used a polycarbonate type of polymer for the bioreactor housing. The bottom of the
bioreactor would be made of optical glass. This would allow for imaging of the scaffolds while they are
in the bioreactor system and the experiment was still ongoing. The glass would be adhered using silicon
adhesive. The top of the bioreactor could be made of acrylic or some type of clear polymer and would
secure to the rest of the housing body through screws. Inside the housing of this design would be an inlet
and outlet port which has a similar interface to the previous design. The ports would be large enough to
allow for scaffolding to be layered within the ports and medical grade adhesive to be around the
scaffolding to hold it in place and seal the extra-tubular space from the luminal space. This design,
because of its interface with the scaffolding has the same flaws as the previous design. The ability to
achieve a similar orientation of the scaffolding with each experiment would be hard, as well as the
removal of individual scaffolding for time trial experiments. Also, optical glass is an expensive material,
and for our initial prototype may be more than we can afford at the current time, however, in future
iterations of this design after modifications, this may be a plausible addition to the design. The use of
scews to attach the clear polymer to the rest of the housing would also make opening the bioreactor
somewhat tedious. A sketch of the design can be seen in Figure 6.
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Figure 5: Bioreactor design using polycarbonate housing, optical glass bottom and acrylic top to allow for imaging of scaffold
constructs.

The last design that we considered drew from some designs that I had come up with previously,
but largely came from a design created by Amin. The design called for a tubular housing compartment
that would have a window cut into the housing tube. Within the tube would be two caps at each end that
would have inlet and out let ports on each exterior end respectively. Between these two caps would be
where the scaffolding would be. The scaffolding in this design was held in place by a cartridge design
that would screw into the end caps at either end. The cartridge design had individual holes for each
scaffold tube to attach too thus allowing for adequate spacing to be maintained between scaffolds for easy
removal of the scaffolds. The disadvantage of this design is that it would require much more
manufacturing on our part than the other designs. With the other designs, more of the components can be
commercially bought. With this design however, the end caps would require custom machining, as would
the housing tube. Yet with this design, we felt that it best identified and remedied the flaws of the
commercial CellMax© system. It allowed easy access to the scaffolding through the window port,
allowed time trial experiments, and could be made of materials that would be able to be autoclaved.
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Figure 6: Sketch of the final design of the bioreactor. The image shows the acrylic tubing on the outside, with the end caps
at both ends and end caps to support the scaffolding.

Figure 7: Image showing the end cap, and scaffold cap that support the scaffolding for the final bioreactor design.

New Bioreactor
To do this project, I, as well as another student Amin Mirzaaghaeian, designed a novel hollow
fiber bioreactor system. After consideration of various designs, we decided to focus on a design that
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utilized a tubular housing, and a cartridge of hollow fibers that could be slid into the tube, with proper
sealing at both ends.
Our main concern in designing this new bioreactor system was the fact that the CellMax©
systems were not reusable. This was a large challenge to the goal of the overall Blood Brain barrier
project since for each experiment we would have to purchase more of the bioreactor systems at $469.00
per bioreactor [12]. For drug companies wishing to test their pharmacologic products this cost may seem
reasonable, but for an academic lab and student experiments, this was beyond our budget. The design of
the CellMax© bioreactors meant that after an experiment was complete, the bioreactor housing had to be
destroyed to get to the hollow fibers. There was no means of take the housing apart so that it could be
reconstructed as the ends of the chamber were sealed as one unit. In order to get access to the hollow
fibers the housing chambers were cut open using a band saw in the departments machine shop with the
help of Lab Technicians Mr. Martin Koch, and Mr. Dave Laiho.
We wanted our new bioreactor to facilitate access to the hollow fibers without compromising the
bioreactor itself. Rather than cutting the housing apart, we decided to cut a window view port into the
side of the bioreactor housing. This would allow for removal of the window inside a sterile laminar flood
hood so that the hollow fibers could be sectioned out for analysis. In selecting the material for the tubing
of the bioreactor, we wanted something that was clear to allow visualization of the scaffolding, but also
something that had strength and wasn’t too brittle. Based on these desires, we selected to use cast acrylic
from McMaster-Carr. While acrylic cannot be autoclaved for sterilization, we were able to have the
material gassed using ethylene oxide. The acrylic used for the housing was a clear cast acrylic tube, 3”
outer diameter, 2.5” inner diameter from McMaster-Carr. We chose this size of tube because it would
allow for maneuverability within the housing when removing scaffolding The window port had a silicon
rubber gasket (McMaster-Carr P/N 5787T63) around its edge which allowed it to properly seal against the
outside of the acrylic housing. The window was then held on using hose clamps with thumb screws that
fit around the acrylic housing and acrylic window. Once the hollow fiber of interest was removed and the
free ends sutured shut, the window could be placed back into position, and the experiment could be
allowed to continue running. Figure 8 shows the housing with the stainless steel end caps in place, and
gives a good view of the window view port.
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Figure 8: Bioreactor prototype. In the image can be seen the hose clamps with the screws that tighten the housing
around the stainless steel parts. The viewport window can be seen cut into the acrylic housing including the silicon gasket
around the edge.

To allow for the reusability of the bioreactor meant that the materials used for the bioreactor
should be able to be sterilized. For the housing of the bioreactor we decided to use a clear cast acrylic
tube. The cast acrylic gives a good optical clarity and is also more impact resistant than other clear plastic
materials. An issue that arises by using this material is that it cannot be autoclaved, which is how a
majority of the sterilizing is performed in our lab. The high temperatures in the autoclave are beyond the
operating range of the acrylic, and results in the acrylic deforming and degrading over time. Instead of
using an autoclave, we decided to try using the Ethylene Oxide sterilizing method and see if the housing
would withstand the process, which it did, as well as any silicon gaskets on the housing. For the cartridge
and end caps that would slide into the acrylic housing we used 316 stainless steel. These can be
autoclaved, and made sterile for repeated use in the bioreactor.
The manufacturing and machining of these materials can all be done in house at the machine
shops at Cal Poly. The 316 stainless steel parts were machined out of house for our first prototype. This
was done because there was limited time to get training on the CNC machines in order to machine some
of the features on the steel, however for future production of other bioreactors, the training to operate
these machines can be completed and the design can also be refined to use some other machining
techniques and materials. The stainless steel parts can be seen in Figure 9. The acrylic parts can also be
machined in the shops at Cal Poly. The acrylic housing was cut using a band saw, while the window that
was cut into the housing was cut using an end mill.
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Figure 9: To the left is an image of the stainless steel parts. At the top and bottom are the endcaps. In the middle are the
scaffolding caps which will hold the scaffolding. The image on the right is all of the parts to the bioreactor disassembled.

Evaluation of Bioreactor Design
After we received our stainless steel parts from the machinist we realized that the depth for the oring groove was cut too deep to fit the standard size o-rings we had selected from Cole-Parmer. We
believe that this can either be attributed to an error made in our SolidWorks© designs that we had sent in,
or that the machinist made. To remedy this we layered the o-rings that we had originally planned to use
in the groove. To test if this solution allowed for the housing chamber to be properly sealed against the
stainless steel parts, we put the system together, then filled the chamber with water and left the bioreactor
to sit for 24 hours. After the 24 hours we found that there was water that had leaked out and deemed that
we needed to follow this up with an alternative solution. We thought that perhaps using o-rings with
different durometer may provide a tighter seal against the bioreactor housing. We tested o-rings of
varying durometers but decided upon o-rings with a shore A:70 durometer. This durometer wasn’t too
soft to the point that it would tear when the cartridge was placed inside the housing, but also wasn’t too
hard so as to prevent the o-ring from forming a proper seal. Yet the o-rings still didn’t prevent the system
from leaking. To resolve this problem Amin developed the idea of cutting the bioreactor longitudinally
along its axis. We had previously discussed making the acrylic tube two pieces that were hinged together
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and could be closed around the steel parts but thought this too difficult to seal. So, to compromise
between the hinged tube idea and our initial prototype, we made one cut longitudinally, thus leaving the
tube as one piece. Into this cut we placed some of the same silicon gasket material used to seal the
window against the housing. Hose clamps with screws were used to tighten the acrylic housing tube
around the stainless steel parts. Using this method of cutting the housing in addition with the hose clamps
with screws and the layering of the original silicon rubber o-rings, we were finally able to seal the
housing and prevent water from leaking from the housing after 24 hours. We also performed this test
over a period of 72 hours, and there was still no leaking that occurred. A benefit of creating this cut down
the longitudinal axis was that assembling the bioreactor became easier. Before, sliding the stainless steel
end caps into the acrylic housing was somewhat difficult due to the amount of friction created by the tight
fit between the o-rings and the acrylic housing. The current modification to the housing, inserting the
stainless steel parts is much easier. The assembled bioreactor can be seen in Figure 10.
To further evaluate the bioreactor we hooked the system up to the CellMax© DUO pump system
to be sure it could handle the pressure from the pump. From Bryan’s work with the system, we knew to
select the smallest pin size for the pump in order to get the proper physiologic flow and shear stress. We
then hooked the inlet and outlet ports of the bioreactor to the pump accordingly and turned the system on
using water as the medium. Since we hadn’t developed scaffolds yet for our bioreactor at this point, we
used two 18 gauge stainless steel hypodermic tubes which we had left over from our mandrel design for
electrospinning which will be detailed later. The other holes in the scaffold caps were plugged using
medical adhesive that was used to secure the scaffolding. The space outside of the tubes in the bioreactor
housing was left empty and void of water. We had already proved that this area could hold water, and
had no leaks, this test with the pump was to see if there was leaking between the scaffold caps and end
caps of the device. With no water inside the extra-tubular space, if any water started to accumulate there,
we would know there was leaking occurring. We then turned the pump on at the lowest setting which
was the setting that Bryan had determined gave the proper shear and flow rates. After allowing the
system to run for a few hours, we came back and found that there was no water that had leaked into the
extra-capillary space, indicating that there was a proper seal between the scaffold caps and the end caps of
the bioreactor. To be sure that the seal would hold, we turned the pump up to a higher setting and found
that it was still able to hold water.
Once we had confirmed that the bioreactor housing was properly sealed and would not leak and
compromise the sterility of any experiments being performed, we felt that the next step would be to
attempt using cells in the system. If we could confirm that our system allows for cell adhesion and shares
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similar properties as those in vivo, then we would be able to begin experiments to attempt to recreate the
blood brain barrier. However before we could put cells in, we needed to obtain a material to use for
scaffolding.

Figure 10: The above image is the fully assembled bioreactor.
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Scaffolding:
Once the design of the bioreactor and the housing was complete, and it no longer leaked;
we needed to determine what to use for the scaffolds that would be held within the bioreactor.
The scaffolds that were used in the commercial bioreactor were polypropylene tubes coated in
ProNectin™ F which acts to help cells adhere to the scaffolding. Inside the commercial
bioreactor system there were 60 of these tubes. Each fiber has an inner diameter of 480μm, wall
thickness of 150μm, an average pore size of .2 μm, an inner surface area of 100cm2 and an extracapillary space volume of 1.5mL. The choice of polypropylene was made since it allows cells to
adhere in environments where there will be shear stress and gas diffusion. The hydrophobic
membrane allows the diffusion of gasses but not proteins or other molecules, similar to the
epithelial tight junctions seen in the blood brain barrier. Our goal was to use a material that was
similar to the commercial bioreactor, yet could either be made in house, or be purchased without
exceeding our funds.
Scaffolds within Our Bioreactor
Our bioreactor was designed to only hold 8 scaffolds. We believed that eight would give
us a good number to sample from to perform time-point experiments, and also allowed excision
of scaffolding without the bioreactor chamber becoming too crowded with scaffolding. If more
or less scaffolds are desired, other end caps can be made to accommodate various sizes, patterns
and numbers. Only using eight scaffolds also allows us to use less scaffolding material per
bioreactor and thus save costs on material purchases.
When trying to search for distributors of hollow fibers that met the specifications for our
bioreactor, we had trouble finding products that would fit within our budget. From GE
Healthcare a sterile ready-to-process hollow fiber cartridge of scaffolds with 10 kD molecular
cut off, and .5mm inner diameter size cost approximately $1,075 [13]. Alone this would have
taken up the entire budget for our project. It was also difficult to find producers of polymer
tubing that matched the characteristics that we wanted for our bioreactor. We tried contacting
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several companies, such as Zeus Inc.©, but either wouldn’t always hear back or didn’t receive
much help in finding the product that we needed.
Electrospinning
At this point we decided to try creating the scaffolding in house. There are various
means to create polymer scaffolding such as dipping mandrels into polymer solution and letting
them dry, then sliding them off the mandrel. However, this process wouldn’t yield the correct
material characteristics for what we needed in order to recreate a blood brain barrier model. Our
lab does perform electrospinning experiments to create scaffolding for blood vessel mimics
experiments. Electrospinning is a process that can make a polymer scaffolding by using
electrical charge to draw out long, fine fibers of a liquid polymer. These fibers are collected on a
collector that can be of various shapes and sizes. In our case, the collector was a mandrel that
spins and forms a tube using poly (lactic-co-glycolic acid) or PLGA. Creating the scaffolding
this way provides many benefits.
Benefits of Electrospinning
First off, the electrospinning process of collecting these fibers results in a very stochastic
looking pattern of webs and fibers under high resolution. This characteristic is beneficial
because it acts to more accurately mimic the natural environment in the body which has various
layerings of fibers of collagen and other natural connective tissue materials. The more natural
patterning of the material may allow for better adhesion of cells to the scaffold and facilitate a
better anchoring of the cells, especially under shear stress forces. The patterning may also allow
for a more natural blood brain barrier endothelial phenotype of the cells once they have been
cultured on the material. Also this layering of fibers creates many pores in the material, and fine
tuning the various aspects of this process can allow control over the characteristics of the pores
as well as the fiber sizes that comprise the scaffold.
Another benefit of performing the electrospinning is that our lab has experience using
electrospun scaffolds. Purchasing scaffolding material from a commercial dealer would mean
we would have to totally evaluate the new material and it’s properties in regards to cell adhesion
and growth. By using the electrospun scaffolds that we create in house, we can use the previous
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experience of our labs work with these scaffolds to more quickly optimize the scaffolds for use
in our blood brain barrier system. The PLGA scaffolds have been used in the blood vessel
mimic models performed by other students in the lab, and they have shown that endothelial cells
will adhere and display proper phenotype on the scaffold. Other students have also been
working on performing cryo-sectioning and histological analysis on blood vessel models using
this scaffolding material. Also by doing this in house, we would be able to tailor our scaffolds
slightly to experiment with what characteristics are essential to creating a blood brain barrier
phenotype. With all the research and experiments being performed on the material in our lab
currently, much of the groundwork has been laid out to use this material, and doing so will save
us time and money in developing our blood brain barrier model.

Figure 11: Image of the electrospinning machine at Cal Poly.

Mandrel for Blood Vessel Mimics
The student who currently has led the experiments and research on electrospinning PLGA
scaffolds is Yvette Castillo. She has worked to develop various different experiments to
determine what the best settings are in order to create a scaffolding that facilitates the best
environment for endothelial cells for blood vessel mimics. Some of the various factors that
contribute to the characteristics of the PLGA scaffolding include percentage of polymer in
solution, flow rate of the polymer, electric charge, distance to the collector, and rotation of the
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mandrel. Most of her current work has been done to create scaffolds for the blood vessel mimics
being pursued in the lab. These require larger diameter tubes than what we want for our blood
brain barrier model. The collecting mandrels used for the blood vessel mimics are 4mm in
diameter, 14cm in length and are made of 303 stainless steel. The mandrels feature a shallow
hole drilled into one end to allow attachment of a live center on the machine for the mandrel to
spin. The live centering interface is attached to a threaded screw that can be moved in and out to
allow for the mandrel to be held tightly in place. The other end of the mandrel has a 1/16”
diameter, ½” length stainless steel slotted spring pin put through both sides. This pin acts as an
interface with the driving component of the electrospinner and allows for the mandrel to be spun
in order to allow collection around the rod.

Figure 12: Live centering interface of the electrospinning machine. The pin that acts to center the mandrel is within the
cylinder shown in the image.
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Figure 13: The interface end that drives the pin end of the mandrel and spins the mandrel.

Designing our Own Mandrels
In order for us to electrospin scaffolds for use in a blood brain barrier model, we need
mandrels that are a smaller diameter. A point of contention was what the exact size of the
smaller mandrels should be in order to get the best results in our model. Most all models of the
blood brain barrier experiments in the literature use 1mm or smaller diameter hollow fibers. One
source we found that listed desirable characteristics for scaffolding in a bioreactor similar to ours
was in U.S. Patent 6667172 by Damir Janigro and Mark S. McAllister [14]. From their
assessment, to get a proper phenotype for a blood brain barrier model, the scaffolding should
have a molecular weight cut off of anywhere from 1kD to 1000kD, and a pore size from .01μm
to 5μm (or they say ideally from .01-.64μm). They also say that the inner diameters for the
hollow fibers should be between 20μm and 1000μm, larger than this can limit the diffusion, and
smaller makes the scaffolding difficult to create and to seed cells onto. They state that the wall
thickness should be approximately 2μm to 200μm. These are some of the requirements that we
want to have our scaffold meet. We decided that an inner diameter of 1mm would be the best for
our design. Smaller diameters would make the handling of the scaffolds difficult and increase
the risk of damaging the scaffolding. We created holes in our scaffold caps that allow for
scaffolds with an outside diameter of 2mm, but plan on the outside diameter of the scaffolds to
be approximately 1.5mm, meaning the wall thickness would be approximately 250μm. One
24

characteristic that wasn’t in the literature but that we were aiming for was to have a fiber size of
approximately 2μm to facilitate proper cell growth and adhesion.
Mandrel Design Considerations
In order to create this we needed to create our own mandrel collector since the current
ones are too large. The mandrel needed to fit in the machine’s interface points but still allow for
easy removal of the scaffold from the mandrel once the process was complete. In order to do
this, many different mandrel designs were devised.
One design we considered was to just modifying the current mandrels by machining the
center of the mandrel down from a 4mm diameter to 1mm diameter. The idea was that by doing
this, it would not require the purchase of more stainless steel stock, and would only require the
use of a lathe. However, machining the mandrel down to such a small diameter would prove
difficult on the lathe. Also, if we only machined the middle, then the barbell shape of the
mandrel would prevent the scaffolding from being able to slide off the mandrel.
The second design considered was similar to the first, but addressed the issue of
removing the scaffold. It would require the 4mm mandrels to again be machined down, but
instead of just machining down the middle portion of the mandrel, we would machine down
about ¾ of the mandrel’s length. This would provide a means of removing the scaffold by
sliding it off the end of the mandrel. Yet this doesn’t identify the issue of machining the steel
down to such a small diameter. It is unlikely that you would be able to machine the steel down
to this diameter without damage the mandrel. Also it would be difficult to get a good finish on
the mandrel because the material would likely flex when it got down to a small diameter. This
would make removing the scaffold from the mandrel harder as there would be increased friction,
and the fibers would likely be torn and sheared as they were caught on the rough surface of the
mandrel. Also if the mandrel was machined down to 1mm, it would be hard to have a deep
enough dimple to align in with the live center so that the mandrel stays centered while spinning.
At one point we considered trying to use just a 1 mm diameter stainless steel rod, similar
to the original mandrels used, but with the entire rod at this diameter. This would allow us to
remove the scaffolding without having to worry about a poor finish on the surface of the metal
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that might damage the inner surface of the scaffold. There would also be minimal machining
that needed to be done on the mandrel. This would mean that students would not need to gain
training on the lathe, and time machining would be minimized. An issue with this design;
however, is the need to have interfaces with the electrospinning machine. To try to put a 1/16”
pin through the 1mm rod would mean trying to drill a hole into the 1mm rod. This would prove
to be extremely difficult, and would risk damaging the rod if the drill slipped on the small
surface of the rod. The interface with the electrospinning machine at the other end of the rod
where it interfaces with a live center would also prove difficult to incorporate since drilling onto
the end of the small diameter rod would prove difficult.
The last design that was developed looked at modifying the idea of using a 1mm rod.
Rather than trying to place the 1/16” pin through the 1 mm rod, we decided it would be best to
attach something to the 1mm rod that had a larger diameter, and would thus allow the pin to spin
the rod. While looking for something that could be used to attach to the rod, Mr. Laiho and I
thought of the idea of using collets similar to ones that are on the end of drills and allow for
different drill bits to be used on the drills.
Manufacturing the Mandrel
After searching on McMaster Carr, Mr. Laiho found several pin vises that would work
and ordered some that had various collet sizes in order to determine which would best hold the
1mm rod. The ones that were ordered were 5/16” in diameter, and 3 ¾” long with pin vise sizes
ranging from 0-.125” (P/N 8455A12). These were fairly cheap and cost $12.84 each. These pin
vises were double-ended, meaning that there was a pin vise at each end. The pin vise was then
cut in the middle so that there were now two separate pin vises. The collets that were in the vises
could hold various sized object depending on which end was facing outward. While we only
needed one size to hold our 1mm rod, this gives our lab the options of using various small
diameter rods to act as a collector for the electrospinning machine, and thus many different
experiments can be performed to determine what size scaffolding works best for various types of
models. For the end of the pin vises that had been cut to separate the double ended pin vise into
two separate pin vises, a 1/16” hole was drilled through the diameter of the pin vise, and the
1’16” pin was placed through it to allow for the vise to be spun, an image of this can be seen in
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Figure 5. Now that the attachment for the rod was finished, we needed to find 1mm stainless
steel rod.

Figure 14: The top image shows the pin vise that was modified to fit into the electrospinning machine interace. The
bottom image shows the pin that was put through the diameter of the pin vise to allow for the spinning drive to spin the
mandrel.

The original hope for the rod was to find a solid 1mm 303 stainless steel rod. At this
diameter however, there were not any internet searches that turned up products; instead, all
searches regarded the use of 1mm wire instead. Wire would not work for our purpose as it
would bend and flex and could distort the fibers, as well as not being able to fit the interfaces of
the electrospinning machine. We considered stiff wires such as piano wire as it may have proved
more durable; however, it could also have bending issues. I then looked into using hypodermic
spinal needles, searching various vendors; however, showed that these needles were very
expensive. At Atlantic Medical Supply Inc. the price for a box of ten 18 gauge spinal needles
that were 6” long each was $98.00. Instead, I found 3’ stock hypodermic tubing available on
McMaster Carr that was listed at $12.75 and which we ended up purchasing. The hypodermic
tube could easily be held by the pin vises, and since it was tubing and thus hollow, the hole
provided a means for interfacing with the live centering hole. The 19 gauge hypodermic tubing
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was precision miniature 304 stainless steel, welded and drawn with an outer diameter of
1.0668mm. 304 stainless steel has essentially the same material properties as the 303 stainless
steel that was used with the original electrospinning mandrels, yet is slightly more difficult to
machine. Yet with the size of the material we are using, and the limited amount of machining we
would be doing on this tubing, this would not present itself as an issue. With the attachment we
had created, we were not sure what length of rod would be best to fit in to the electrospinning
machine. Having the stock tube would allow us to cut various lengths and then determine which
fit best into the machine, and being tubing and not solid rod, had added rigidity that would
prevent it from easily being bent. Once we had the stock hypodermic tubing, we decided to cut
the tubing at lengths of 5 ½” and 5” and add the pin vise attachment to each. Then to determine
which length would best fit into the electrospinning machine, we tried to fit each into the
interfaces of the machine and found that the 5” rod worked the best. An image of the finished
mandrel can be seen in Figure 15.

Figure 15: The image to the left shows the mandrel in complete assembly. The stainless steel hypodermic tubing fits into
a collet which the pin vise tightens around. The image on the right shows the pin vise and hypodermic tubing separately.

Testing the Mandrel
The next step was to run the electrospinning machine with the newly made mandrel in
place. One concern of ours with this project was how the mandrel would handle being spun at
high speeds. The pin vise, while small, had considerable weight to it since it was made of steel.
Our fear was that if the mandrel was off center in the machine, it could harm the drive of the
electrospinning machine, or perhaps even fly off the machine and injure the students performing
the experiment. Because of the safety concerns, Yvette Castillo and I tested the mandrels in the
presence of Mr. Laiho. The electrospinner was in a fume hood, with polymer box encasing it,
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further preventing any injury form occurring if the mandrel did spin off. Once the mandrel was
in place the translation setting of the mandrel was set to 3, and the rotation speed was set to 5 on
the machine. There were no issues with the mandrel coming out of the machine interfaces
during spinning. The mandrel did however seem to show some slight bending when spun in the
machine, although it is very slight, and we don’t believe it is significant enough to cause issues
with collecting the scaffolding polymer.
Once we knew that the mandrel would be able to interface correctly with the machine we
wanted to try creating some scaffolds. The new 1 mm mandrel was given to Yvette to spin.
Since we weren’t sure how the scaffolds would turn out, similar settings that were used for the
normal blood vessel mimic scaffolds were used to create the blood brain barrier scaffolds. The
settings used to create our scaffolds was a distance of 8 inches form polymer syringe to collector,
a flow rate of 6.0mL/hr, a solution of 15% PLGA, and a voltage of 18kV. Initially a volume of
3mL of solution was spun onto the mandrel however as can be seen in the next section this
created very thick wall thicknesses and for the subsequent spin a smaller volume of solution was
used. When we received the spun mandrels from Yvette, we discovered that the pin vise was
covered along with the length of the mandrel. In order to get the scaffolding off from the
mandrel we used a scalpel blade to cut around the circumference of the rod up next to the pin
vise, and then slid the scaffolding off from the rod.
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Evaluating Scaffolds
Scanning Electron Microscope
Once the scaffolds were created using the electrospinning machine we needed to evaluate
some of the characteristics of the scaffolding. Preferably we wanted scaffolding that met some
of the characteristics outlined in previous literature. The main things that we want to
characterize with our scaffolds are the fiber sizes, the wall thickness, and the porosity of the
material. To do this we require some means of viewing the scaffolds at very high
magnifications. In order to do this we used a scanning electron microscope (SEM). A scanning
electron microscope works by sending a high energy beam of electrons at the object being
imaged. The beam is then moved across the object in a raster pattern, and the resulting electrons
and x-rays are collected and processed to produce a highly detailed image of the surface of the
object. SEM’s range in size and the magnification level that they can produce. On campus Dr.
Lily Laiho has two desktop SEM’s that are for our department to use and have previously been
used to evaluate electrospun scaffolds. Yvette ran the mandrel once using the same settings she
uses for the blood vessel mimic scaffolds. When we got the scaffoldings from her we cut the
scaffolding and slid it off the mandrel as previously mentioned. Then we imaged the scaffolding
at various magnifications in order to get an idea of the characteristics of the scaffold.
ImageJ Evaluation of Wall Thickness of the 1st Scaffold
To image the scaffolds we cut various sections off of them. We made a cross section cut
to allow us to evaluate the wall thickness of the scaffold, as well as the fiber size. We also made
some cuts longitudinally down the length of short sections of the scaffolding in order to give
ideas of the fiber diameters and variations in fiber size within the scaffolding. With the first spin
that Yvette created, we found that the wall thickness of the scaffolding was larger than we had
desired. Previous literature had stated that a wall thickness of about 200μm was appropriate for
blood brain barrier models, and our goal for these scaffolds was approximately 200-300μm. A
macro SEM cross sectional image of the first scaffold created can be seen in Figure 16.

Using

the measure feature in the ImageJ software, I was able to measure the wall thickness of the
scaffolding by setting the scale to match the scales provided at the bottom of each image. The
images I used to determine the thickness of the walls can be seen in Figure 17 and Figure 18. To
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determine this thickness I would measure from the inside of the luminal wall to the exterior wall.
Within each image I would measure in the middle of the cross section, as well as the top and
bottom halves of the image. In some images measuring to the exterior wall became difficult as
some of the fibers appeared to be frayed and were coming off from the bulk of the scaffold wall
so that a definite edge was hard to determine. After collecting wall thickness measurements on
both images I averaged the values to get an average wall thickness of 1042μm. This was much
thicker than the 200μm range that we had hoped for, however we felt that an easy solution to this
would be to use less volume of polymer solution on the next spin, so instead of using 3mL,
approximately 1mL was used. While the wall thickness on this first scaffold was not what we
had hoped for we still wanted to evaluate the fiber size to get a rough approximation of how this
scaffold compared to the literature.
Measuring Fiber Size of the 1st Scaffold
For measuring the fiber size we used images that were taken of the lumen of a
longitudinal cross section of the scaffolding tube. The same method used to measure the wall
thickness of the scaffolding was used to measure the fiber sizes. This data was collected from
Figures 19 and 20. The images were split into 6 square areas, with one measurement of a fiber
taken from each area, so 6 measurements were taken from each image for a total of 12
measurements. These measurements were then averaged together to get an average fiber size of
5.39μm with a standard deviation of 2.56μm. This indicates that there was a varying degree of
fiber sizes in the scaffold. Some of the fibers appeared fairly large, which would not be ideal for
our endothelial cells to adhere to, but the exact parameters that control fiber size are still being
determined by students performing experiments with the electrospinning machine, and hopefully
will be optimized in the future to provide the best results. This fiber diameter should still work
well enough for our initial tests.
Measuring the Wall Thickness of the 2nd Scaffold
The second scaffold was spun using approximately 1mL of polymer solution in the hope
of decreasing the thickness of the scaffolding wall. The rest of the parameters were kept the
same. Once the scaffold was created, it was then evaluated using the SEM just as the initial
scaffold was. Measurements of the wall thickness and fiber size were taken in similar manner to
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get the same number of measurements. Figures 21, 22 and 23 were the images used for the
evaluation of the wall thickness of the second scaffold. After again inputing this data into excel
and the average wall thickness was found to be 296.43μm with a standard deviation of 60.97μm.
This wall thickness is much closer to our desired wall thickness (between 300-200μm) and I
believe that once we have gained more experience using this mandrel, and effects of the different
electrospinning parameters are better known, we will be able to more accurately produce more
scaffolds with this wall thickness.
Measuring Fiber Size of 2nd Scaffold
For the fiber size measurements Figures 24 and 25 were used. The fiber size
measurement method again followed the same ImageJ protocol that was used with the first
scaffold. After collecting this data, the average fiber size was found to be 5.31μm with a
standard deviation of 2.13μm. This is very similar to the results that were found with the first
scaffold created, and should facilitate our need for now, however smaller fibers would be desired
if possible. The success in creating a scaffold with an ideal wall thickness is a large step for our
project, and will allow us to soon start running experimental tests with cells to determine their
true viability in regards to creating a blood brain barrier model.
Pore Size
One parameter that is important to our project, yet would be difficult to measure through
image analysis is the pore size of the scaffolding. The SEM can only view the surface of the
material, so knowing what pore sizes were deep in the material would be difficult. Even to
attempt to use image analysis of the surface images collected would be difficult since the
material is made of many fibers, and determining of boundaries of pores could be problematic
and inconsistent. Instead of using a direct image analysis method I propose that determining the
pore sizes of the materials would best be done through physical experimental procedures. This
would include using fluorescent microspheres of a known diameter and flowing them under
pressure into the lumen of the scaffold at a known concentration. Then the concentration of the
microspheres that passed through the walls of the scaffold could be measured in any media that
went through the scaffold walls. This would give an idea of average pore size in the scaffold.
Besides using fluorescent microspheres, any molecule of a known size and concentration could
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be used to determine the pore size, however this could take many iterations of the experiment to
get a proper idea of the true relative pore size.

Figure 16: x40 SEM view of the 1st Scaffolding

Figure 17: Image of left side of scaffolding for assessment of wall thickness.
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Figure 18: Image of right side of scaffold for wall thickness measurement.

Figure 19: SEM image of inner lumen of first scaffold for fiber size measurement.
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Figure 20: Second SEM image of inner lumen of first scaffold for fiber size measurement. Black arrows indicate the wall
of the scaffold, with the left side being the lumen.

Figure 21: x60 SEM macro view of the cross section of the second scaffold.
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Figure 22: Image of right wall of the second scaffolding for wall thickness measurement.

Figure 23: SEM image of left wall of second scaffold for wall thickness measurement.
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Figure 24: SEM image of the lumen wall of the second scaffold for analysis of fiber size.

Figure 25: Second SEM image of lumen wall of second scaffold for fiber size analysis.
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Discussion and Conclusion:
The overall focus of this project has been to develop a model of the blood brain barrier in vitro
that would allow our lab to contribute to the field of tissue engineering, as well as drug delivery to the
central nervous system. This project was initially started by former biomedical engineering student Bryan
Brandon, and has since been broken into various aspects and divided amongst several students to facilitate
advancement of the project. Myself and now Amin Mirzaaghaeian have been tasked with working on the
design and creation of an in house bioreactor system to house our experiments and attempts to
recapitulate the characteristics of an in vivo blood brain barrier. T.J. Eames has been working to better
develop the means of biologically testing for markers of a true blood brain barrier model, characterized by
different surface proteins and tight junctions between the endothelial cells.
I have described in this paper what my role has been in the development of the bioreactor for the
in vitro model. My main contributions have been in the design and manufacture of the bioreactor, the
design of the mandrel for creating electrospun scaffolding for our model to be cultured on, and the
evaluation of these scaffolds. The previous system used to initially develop a protocol for culturing
bovine aortic endothelial cells, and C6 glioma cells, was the CellMax© hollow fiber bioreactor cartridge.
While this system allowed us to initially become familiar with the process and steps to create a blood
brain barrier model, we felt there were many shortcomings in its design that didn’t warrant purchasing a
new cartridge for each trial, and that we could improve upon.
The first goal of my portion of this project was the development of a re-usable bioreactor that we
could manufacture in house. We were able to successfully design and manufacture a bioreactor that is
able to be sterilized for reuse, that allows for easy access to the scaffold constructs, and allows for time
trial experiments to be performed using one bioreactor system. All these elements of our bioreactor are
improvements over the single use CellMax© DUO system which requires the housing to be destroyed to
get to the scaffolds. The parts that our bioreactor is composed of are all able to be manufactured in the
Cal Poly machine shops and can be made by students who have received the proper training. While our
bioreactor has improved upon the commercial system, it wasn’t without its own issues. We had issues
with sealing our bioreactor housing. Yet throughout the manufacturing and design process we were able
to troubleshoot the various problems that we had and create a bioreactor that is liquid tight, and can be
tailored to various experimental design formats.
Once we had completed the design for our bioreactor, we needed scaffolding to act as the
construct for our blood brain barrier model. After trying to investigate commercial polymer tubes to
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purchase and failing to find a viable option, we decided that we could create our own in house PLGA
electrospun scaffolds. We already had an electrospinning machine, and with the work being done with
the electrospinner by students, we can soon tailor the scaffold to the right material parameters that we
desire. The electrospinner generates a scaffold environment that can be made to properly simulate the
environment that the native cells in the body would experience. In order to use the electrospinning
machine for our model and experiment, we would need to create a new mandrel to act as a collector to get
the proper dimensions for the construct. Doing so required more consideration than we previously
thought since we had to incorporate the mandrel into the current interfaces on the machine, which were
tailored for larger mandrel sizes. However, as presented in this paper, we were able to successfully create
a mandrel that interfaces properly with the machine, while still allowing proper collection of the
electrospun polymer.
The final portion of the project was to evaluate the electrospun scaffolds that were created on our
mandrels. The evaluation method used image analysis to determine the fiber size, and wall thickness of
the scaffolding. This was carried out using the ImageJ software, and upon of refinement was able to get
scaffolding with the proper wall thickness and close to the correct fiber size. With further work being
performed by students to characterize what the different parameters of the electrospinning process do in
regards to the material characteristics of the final product, I believe that we will soon be able to create
scaffolds that can be tailor made to fit out model specifications.
This project is continuing on the groundwork laid out by Bryan Brandon and his work to develop
various protocols for creating a blood brain barrier model in vitro. Through his work we were able to
recognize the need for a novel bioreactor. The commercial system had many shortcomings which we felt
we had the ability to address and improve upon. By creating these bioreactors in house we will
effectively reduce the cost of the system, make the system more user friendly, and improve the
convenience of the system to facilitate better experiments.
While we have made progress with this portion of the project, there is still room for more work to
be done. While we were able to create a few electrospun scaffolds and evaluate them using SEM, cells
still need to be sodded onto the scaffolds to ensure that they will adhere properly. Once we are sure that
cells will adhere to the scaffolds, we can run the entire system with cells and evaluate the effectiveness of
the system in simulating the blood brain barrier environment and its ability to culture the BAEC’s and C6
glioma cells.
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Future work can also be performed on the design of the bioreactor. The bioreactor that we have
created is a prototype and still has many features that can be optimized. With our initial design hopes, we
had planned to manufacture the parts through rapid prototyping; however we couldn’t find the correct
equipment on campus to create our parts. Yet with further research, we believe materials better suited for
this project and cheaper could be found.
Overall, I believe that this project is a significant step forward in our pursuit to create a blood
brain barrier model. We have created a new design for an in house bioreactor, and have seen the project
through to an initial prototype. Our prototype design has been shown to be liquid tight, is reusable,
allows easier access to the scaffolding constructs, and allows for time trial experiments. The importance
of the ability to perform time trial experiments will prove important in further development of our system
with a culturing of the C6 glioma cells and bovine aortic endothelial cells to show the proper model
development. The hope is that with further refinement and experiments, we will be able to use our model
to test the effectiveness of drugs to cross the blood brain barrier and target various pathologies and
diseases that affect the central nervous system. The early nature of this project provides many aspects
that can be the focus of future senior projects and master’s theses.
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